New Tools in Diagnosis and Therapy


 

In the future, the Identification of the biochemical and molecular factors and related genes linked to the onset and progression of diseases (biomarkers) will guide the choice of therapies and also the segregation of patients who are most likely to benefit from a given therapy. The development of biomarkers for diseases (with a particular focus on cancer and rare diseases) would probably overcome the current limitations in the technologies of genomics and proteomics, and may change the practice of Clinical Medicine, with unforeseen economic consequences.

Area coordinator:

Prof. Ángel Rodríguez de Lera

Organic Chemist.

More info: Organic ChemistryCINBIO

Leaders:

David Posada. More info: Phylogenomics

Florentino Fernández Riverola. More info: Bioinformatics

Ana Gago Martinez. More info: Analytical and Food ChemistryCINBIO

Lines of research:

  • Epigenetic changes in diseases.
  • Synthesis of epigenetic modulators.
  • Pharmacogenomics and pharmacogenetics of diseases.
  • New biosensors.
  • New tools for biomedical applications.
  • Data analysis (genomic/proteomics)

RELATED NEWS

Pages

Friday, February 7, 2014
The group of Ángel de Lera has written a review article about the functions of this vitamin to commemorate the 100th anniversary of its discovery
Thursday, January 2, 2014
Cancer Immunotherapy has been chosen the "scientific advance of the year' by 'Science'.
Friday, December 27, 2013
BIOCAPS organized a meeting in Vigo of experts in the diagnosis and treatment of a disease that caused more than 14 million new cases worldwide in 2012